Development of agents for the treatment of systemic sclerosis

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.7, 2001-07, pp. : 1255-1264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

Letters in Drug Design & Discovery, Vol. 5, Iss. 2, 2008-03 ,pp. : 134-136

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Mycophenolate Mofetil for the Treatment of Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 11-14

Bentham Science Publishers

Access to resources Recommend Favorite

New agents for treatment of systemic fungal infections

By Arikan S. Rex J.H.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 2, 2000-07 ,pp. : 135-160

Informa Healthcare

Access to resources Recommend Favorite

Chelating Agents for the Treatment of Systemic Iron Overload

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2816-2827

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Application of Anti-inflammatory Agents in Periodontal Treatment

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite